-
公开(公告)号:US20120315298A1
公开(公告)日:2012-12-13
申请号:US13524590
申请日:2012-06-15
申请人: Ruihong CHEN , Allan E. Rubenstein , Xiaodong Shen , Scott Stewart , Jin-Chen Yu
发明人: Ruihong CHEN , Allan E. Rubenstein , Xiaodong Shen , Scott Stewart , Jin-Chen Yu
IPC分类号: A61K31/437 , A61K31/513 , A61K31/7064 , A61K31/357 , A61K31/196 , A61K31/65 , A61K31/4184 , A61K31/165 , A61K31/19 , A61K31/395 , A61K31/336 , A61K31/517 , A61K31/7036 , A61K31/436 , A61P25/00 , A61P35/00 , A61P29/00 , A61P37/02 , A61P37/04 , A61P37/06 , A61K31/661
CPC分类号: A61K9/0019 , A61K9/0014 , A61K31/165 , A61K31/167 , A61K31/19 , A61K31/196 , A61K31/282 , A61K31/366 , A61K31/395 , A61K31/4184 , A61K31/4745 , A61K31/513 , A61K31/65 , A61K31/661 , A61K31/675 , A61K31/7064
摘要: A method for treating a neurofibroma, e.g. dermal neurofibroma, a subdermal neurofibroma, or a superficial plexiform neurofibroma, in a subject in need of such treatment is disclosed. The method comprises locally applying a composition to a neurofibroma either topically or intralesionally. This method does not encompass systemic administration of the composition to the subject to have an effect on the neurofibromas. Compositions useful for such treatments and methods of preparing the compositions are disclosed.
摘要翻译: 一种治疗神经纤维瘤的方法,例如 公开了在需要这种治疗的受试者中的真皮神经纤维瘤,皮下神经纤维瘤或浅表丛状神经纤维瘤。 该方法包括局部地将组合物局部施用于神经纤维瘤,或者局部或间质地。 该方法不包括对受试者的组合物的系统给药以对神经纤维瘤具有影响。 公开了可用于这种处理的组合物和制备组合物的方法。
-
2.
公开(公告)号:US20100292218A1
公开(公告)日:2010-11-18
申请号:US12631667
申请日:2009-12-04
IPC分类号: A61K31/55 , A61K31/365 , A61K31/4523 , A61K31/497 , A61K31/5377 , A61K31/541 , A61K31/4025 , A61K31/4427 , A61K31/454 , A61P35/00
CPC分类号: A61K31/365 , A61K31/4025 , A61K31/4427 , A61K31/4523 , A61K31/454 , A61K31/497 , A61K31/5377 , A61K31/541 , A61K31/55
摘要: The present invention provides compounds of formulae Ia, Ia′, IIa, IIa′, IIIa, IIIa′, IVa, or Va and the therapeutic use thereof. The present invention also includes methods of treating NF2-deficient or NF1-deficient cells or neurodegenerative diseases with radicicol or its derivatives, such as one or more compounds of formula I, II, III, IV, V, Ia, Ia′, IIa, IIa′, IIIa, IIIa′, IVa, or Va. Furthermore, the present invention is directed to methods of inhibiting the growth of NF2-deficient or NF1-deficient tumors. The methods comprise contacting NF2-deficient or NF1-deficient tumor cells with radicicol or its derivatives, such as one or more compounds of formula I, II, III, IV, V, Ia, Ia′, IIa, IIa′, IIIa, IIIa′, IVa, or Va. The present invention is also directed to the combinational use of radicicol or its derivatives, such as one or more compounds of formula I, II, III, IV, V, Ia, Ia′, IIa, IIa′, IIIa, IIIa′, IVa, or Va with at least one additional active agent, such as one or more HSP90 inhibitors.
摘要翻译: 本发明提供式Ia,Ia',IIa,IIa',IIIa,IIIa',IVa或Va的化合物及其治疗用途。 本发明还包括用根赤壳菌素或其衍生物如一种或多种式I,II,III,IV,V,Ia,Ia',IIa的化合物治疗NF2缺陷型或NF1缺陷型细胞或神经变性疾病的方法, IIa',IIIa,IIIa',IVa或Va。此外,本发明涉及抑制NF2缺陷型或NF1缺陷型肿瘤生长的方法。 所述方法包括将NF2缺陷型或NF1缺陷型肿瘤细胞与根霉菌或其衍生物接触,例如一种或多种式I,II,III,IV,V,Ia,Ia',IIa,IIa',IIIa,IIIa化合物 本发明还涉及根尖星曲菌素或其衍生物如一种或多种式I,II,III,IV,V,Ia,Ia',IIa,IIa'化合物的组合使用, ,IIIa,IIIa',IVa或Va与至少一种另外的活性剂,例如一种或多种HSP90抑制剂。
-